Renal cell–expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis

Center of Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Journal of Clinical Investigation (Impact Factor: 13.77). 06/2005; 115(5):1199-209. DOI: 10.1172/JCI23348
Source: PubMed

ABSTRACT TNF is essential for the development of glomerulonephritis, an immune-mediated disorder that is a major cause of renal failure worldwide. However, TNF has proinflammatory and immunosuppressive properties that may segregate at the level of the 2 TNF receptors (TNFRs), TNFR1 and TNFR2. TNFR1-deficient mice subjected to immune complex-mediated glomerulonephritis developed less proteinuria and glomerular injury, and fewer renal leukocyte infiltrates at early time points after disease induction, and this was associated with a reduced systemic immune response to nephrotoxic rabbit IgG. However, proteinuria and renal pathology were similar to those in wild-type controls at later time points, when lack of TNFR1 resulted in excessive renal T cell accumulation and an associated reduction in apoptosis of these cells. In sharp contrast, TNFR2-deficient mice were completely protected from glomerulonephritis at all time points, despite an intact systemic immune response. TNFR2 was induced on glomerular endothelial cells of nephritic kidneys, and TNFR2 expression on intrinsic cells, but not leukocytes, was essential for glomerulonephritis and glomerular complement deposition. Thus, TNFR1 promotes systemic immune responses and renal T cell death, while intrinsic cell TNFR2 plays a critical role in complement-dependent tissue injury. Therefore, therapeutic blockade specifically of TNFR2 may be a promising strategy in the treatment of immune-mediated glomerulonephritis.

Download full-text


Available from: George Stavrakis, Jun 06, 2014
  • Source
    • "were prepared freshly every day. The chemical properties of GA have been fully reviewed before (Ali, Ziada, & Blunden, 2009; Vielhauer, Stavrakis, & Mayadas, 2005). The SUPERGUMTM EM 10 used was characterized by size fractionation followed by multiple angle laser light scattering (GPC-MALLS) to give its molecular profile. "
    [Show abstract] [Hide abstract]
    ABSTRACT: INTRODUCTION: This study aimed at comparing the effects of feeding mice and rats with adenine to induce a state of chronic renal failure (CRF), and to assess the effect of treatment with gum acacia (GA) thereon. METHODS: We compared the outcome, in mice, of feeding adenine at three different doses (0.75%, 0.3%, and 0.2%, w/w). Biochemical and histopathological studies were conducted in plasma, urine and renal homogenates from both species. RESULTS: When mice and rats were fed adenine (0.75%, w/w), all treated rats survived the treatment, but all treated mice died within 1-2 days. The dosage in mice was reduced to 0.3%, w/w, for 4 weeks, but again all treated mice died within 3-4 days. A further reduction in the dosage in mice to 0.2%, w/w, for 4 weeks resulted in no mortality, and produced alterations similar to those observed in rats fed adenine at a dose of 0.75%,w/w, for 4 weeks. Plasma creatinine, urea and urinary protein were significantly increased (P < 0.001) in adenine-treated mice and rats, and this action was incompletely, but significantly (P < 0.05), reversed by GA. Adenine significantly (P < 0.001) reduced superoxide dismutase (SOD) activity and reduced glutathione (GSH) concentration in renal homogenates from both species, and these reductions were significantly (P < 0.05) ameliorated by GA. DISCUSSION: Our data suggest that mice are more sensitive to adenine than rats, and that a dose of adenine of 0.2%, w/w, for 4 weeks in mice is suggested as a model for CRF. In both models, GA (15%, w/v, in the drinking water for 4 weeks) given concomitantly with adenine ameliorated the severity of CRF to a similar extent.
    Journal of pharmacological and toxicological methods 05/2013; DOI:10.1016/j.vascn.2013.05.001 · 2.15 Impact Factor
  • Source
    • "Irrespective of this, it is hypothesized that sTNF-R2 is associated with the deterioration of kidney function in nonobese Japanese subjects with type 2 diabetes. In this regard, the previous report by Vielhauer et al. that renal cellexpressed TNF-R2, but not TNF-R1, is essential for the development of glomerular injury is relevant [32]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: AIMS: Chronic low-grade inflammation and/or obesity are suggested to induce chronic kidney disease (CKD) in patients with type 2 diabetes. This cross-sectional study was performed to investigate the relationship between inflammatory biomarkers and CKD in non-obese patients with type 2 diabetes. METHODS: 106 non-obese Japanese patients with type 2 diabetes were recruited for the measurement of GFR, TNF, HMW adiponectin, leptin, hsCRP and some variables including urinary albumin. BMI, serum creatinine, and urinary albumin levels were 22.2±0.2kg/m(2) (17.1-24.9kg/m(2)), 0.76±0.02mg/dl (0.39-1.38mg/dl), 40.4±4.3mg/gCr (1.6-195.0mg/gCr), respectively. They were stratified into two groups based on the value of eGFR: low eGFR (eGFR<60ml/min/1.73m(2)) and normal eGFR (eGFR>60ml/min/1.73m(2)). Logistic regression analysis was used for statistical analysis. RESULTS: Whereas univariate logistic regression analysis showed that gender, diabetes duration, triglyceride, HDL cholesterol, uric acid, urinary albumin, and soluble TNF receptors (sTNF-R1, sTNF-R2) are associated with the development of stage 3 CKD, multivariate logistic regression analysis revealed that sTNF-R2 (Odds ratio 1.003, 95% confidence interval 1.000 to 1.005, P=0.030) showed significant associations with the development of stage 3 CKD. CONCLUSIONS: Circulating TNF receptor 2 is an independent risk factor for CKD in non-obese Japanese patients with type 2 diabetes.
    Diabetes research and clinical practice 01/2013; 99(2). DOI:10.1016/j.diabres.2012.11.002 · 2.54 Impact Factor
  • Source
    • "For example, TNFR2 is required for renal injury and inflammation in a mouse model of acute renal failure induced by cisplatin, whereas TNFR1 is not (Ramesh et al., 2003). TNFR2 but not TNFR1 is required for the induction of glomerular injury and inflammation in a mouse model of glomerulonephritis (Vielhauer et al., 2005). TNFα acting on TNFR2 receptors in brain microvessels is also required for upregulation of ICAM1 and leukocyte recruitment in a model of cerebral malaria (Lucas et al., 1997). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chamber studies in adult humans indicate reduced responses to acute ozone with increasing age. Age-related changes in TNFα have been observed. TNFα induced inflammation is predominantly mediated through TNFR1. To examine the impact of aging on inflammatory responses to acute ozone exposure in mice and determine the role of TNFR1 in age-related differences. Wildtype and TNFR1 deficient (TNFR1(-/-)) mice aged 7 or 39 weeks were exposed to ozone (2 ppm for 3 h). Four hours after exposure, bronchoalveolar lavage (BAL) was performed and BAL cells, cytokines, chemokines, and protein were examined. Ozone-induced increases in BAL neutrophils and in neutrophil chemotactic factors were lower in 39- versus 7-week-old wildtype, but not (TNFR1(-/-)) mice. There was no effect of TNFR1 genotype in 7-week-old mice, but in 39-week-old mice, BAL neutrophils and BAL concentrations of MCP-1, KC, MIP-2, IL-6 and IP-10 were significantly greater following ozone exposure in TNFR1(-/-) versus wildtype mice. BAL concentrations of the soluble form of the TNFR1 receptor (sTNFR1) were substantially increased in 39-week-old versus 7-week-old mice, regardless of exposure. The data suggest that increased levels of sTNFR1 in the lungs of the 39-week-old mice may neutralize TNFα and protect these older mice against ozone-induced inflammation.
    Inhalation Toxicology 11/2011; 23(14):878-88. DOI:10.3109/08958378.2011.622316 · 2.34 Impact Factor
Show more